×
About 11,613 results

ALLMedicine™ Meningioma Center

Research & Reviews  5,733 results

About a rare pediatric case of myxoid meningioma.
https://doi.org/10.1007/s00381-021-05156-1 10.1002/jnr.23801 10.3109/01913129009032251 10.1177/08830738060210010801 10.14791/btrt.2018.6.e17 10.1111/j.1440-1789.2009.01008.x 10.1007/s00381-019-04142-y 10.5414/NP301139 10.1111/j.1750-3639.2007.00068_3.x 10.1111/j.1440-1827.1998.tb03828.x 10.3171/2011.12.JNS111020 10.1007/s00401-016-1545-1 10.1155/2019/9207632 10.4236/ojpathology.2013.31009 10.1055/s-2007-980204
Child's Nervous System : ChNS : Official Journal of the I... Bedioui A, Rkhami M et. al.

Apr 8th, 2021 - Intracranial meningiomas are uncommon in the pediatric group. Myxoid meningioma is a subtype of metaplastic meningioma. It is the rarest WHO grade I meningioma. Only one case of pediatric myxoid meningioma was described in the literature. We repor...

Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracra...
https://doi.org/10.1093/neuros/nyab100
Neurosurgery Dono A, Chandra A et. al.

Apr 7th, 2021 - Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.|2021|Dono A,Chandra A,Ballester LY,Esquenazi Y,|

Innumerable Meningiomas Arising in a Patient With Tuberous Sclerosis Complex Decades Af...
https://doi.org/10.1177/10935266211006078
Pediatric and Developmental Pathology : the Official Jour... Gilani A, Lee JC et. al.

Apr 7th, 2021 - Meningioma is the most common radiation-induced brain neoplasm, usually occurring after a latency of 20 - 35 years, with multiplicity in 10% of cases. Radiation-induced meningiomas (RIMs) have not previously been reported in patients with tuberous...

see more →

Guidelines  1 results

Stereotactic Radiosurgery for Intracranial Noncavernous Sinus Benign Meningioma: Intern...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566438
Neurosurgery Marchetti M, Sahgal A et. al.

May 28th, 2020 - Stereotactic radiosurgery (SRS) for benign intracranial meningiomas is an established treatment. To summarize the literature and provide evidence-based practice guidelines on behalf of the International Stereotactic Radiosurgery Society (ISRS). Ar...

see more →

Clinicaltrials.gov  5,803 results

About a rare pediatric case of myxoid meningioma.
https://doi.org/10.1007/s00381-021-05156-1 10.1002/jnr.23801 10.3109/01913129009032251 10.1177/08830738060210010801 10.14791/btrt.2018.6.e17 10.1111/j.1440-1789.2009.01008.x 10.1007/s00381-019-04142-y 10.5414/NP301139 10.1111/j.1750-3639.2007.00068_3.x 10.1111/j.1440-1827.1998.tb03828.x 10.3171/2011.12.JNS111020 10.1007/s00401-016-1545-1 10.1155/2019/9207632 10.4236/ojpathology.2013.31009 10.1055/s-2007-980204
Child's Nervous System : ChNS : Official Journal of the I... Bedioui A, Rkhami M et. al.

Apr 8th, 2021 - Intracranial meningiomas are uncommon in the pediatric group. Myxoid meningioma is a subtype of metaplastic meningioma. It is the rarest WHO grade I meningioma. Only one case of pediatric myxoid meningioma was described in the literature. We repor...

Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracra...
https://doi.org/10.1093/neuros/nyab100
Neurosurgery Dono A, Chandra A et. al.

Apr 7th, 2021 - Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.|2021|Dono A,Chandra A,Ballester LY,Esquenazi Y,|

Innumerable Meningiomas Arising in a Patient With Tuberous Sclerosis Complex Decades Af...
https://doi.org/10.1177/10935266211006078
Pediatric and Developmental Pathology : the Official Jour... Gilani A, Lee JC et. al.

Apr 7th, 2021 - Meningioma is the most common radiation-induced brain neoplasm, usually occurring after a latency of 20 - 35 years, with multiplicity in 10% of cases. Radiation-induced meningiomas (RIMs) have not previously been reported in patients with tuberous...

see more →

News  55 results

Increased Risk of Meningioma With Cyproterone Acetate Use
https://www.medscape.com/viewarticle/945218

Feb 2nd, 2021 - New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen and potent anti-androgen that has been used in the treatme...

EU Restricts High-Dose Cyproterone Because of Meningioma Risk
https://www.medscape.com/viewarticle/925271

Feb 13th, 2020 - Cyproterone products with daily doses of 10 mg or more should be restricted because of a risk of developing meningioma, says the safety committee of the European Medicines Agency. Products containing cyproterone 10 mg daily or more should be used ...

Risk of Meningioma With Cyproterone: EMA Review Begins
https://www.staging.medscape.com/viewarticle/915545

Jul 11th, 2019 - The European Medicines Agency (EMA) has begun a review of products containing the anti-androgen cyproterone, which is used in the treatment of hirsutism, alopecia, early puberty, amenorrhea, acne, and prostate cancer. They are also used together w...

Risk of Meningioma With Cyproterone: EMA Review Begins
https://www.medscape.com/viewarticle/915545

Jul 11th, 2019 - The European Medicines Agency (EMA) has begun a review of products containing the anti-androgen cyproterone, which is used in the treatment of hirsutism, alopecia, early puberty, amenorrhea, acne, and prostate cancer. They are also used together w...

A Visual Field Defect in a Patient With History of Seizures
https://www.medscape.com/viewarticle/902828_2

Oct 8th, 2018 - Case Diagnosis Meningiomas are common non-glial central nervous system (CNS) tumors that often appear as lobular, extra-axial masses with well-circumscribed margins. T1-weighted MRI sequences usually show isointensity to slight hypointensity relat...

see more →

Patient Education  21 results see all →